Bioventus Inc.
BVS
$6.56
$0.010.15%
NASDAQ
| 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.46M | -2.64M | -156.00K | -4.82M | -25.68M |
| Total Depreciation and Amortization | 12.05M | 11.87M | -18.01M | 12.28M | 13.09M |
| Total Amortization of Deferred Charges | -- | -- | 5.58M | -- | -- |
| Total Other Non-Cash Items | 5.95M | 2.64M | 34.02M | 3.32M | 22.21M |
| Change in Net Operating Assets | 477.00K | -31.20M | -2.11M | -458.00K | 5.54M |
| Cash from Operations | 25.94M | -19.33M | 19.32M | 10.32M | 15.16M |
| Capital Expenditure | -683.00K | -826.00K | -574.00K | -64.00K | -77.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -686.00K | -- | 24.68M | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -1.37M | -826.00K | 24.10M | -64.00K | -77.00K |
| Total Debt Issued | 0.00 | 15.00M | -- | -- | -- |
| Total Debt Repaid | -5.00M | -5.00M | -48.26M | 0.00 | -8.26M |
| Issuance of Common Stock | 1.32M | 150.00K | 1.10M | 553.00K | 609.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.98M | -9.20M | 4.31M | -191.00K | -190.00K |
| Cash from Financing | -14.66M | 947.00K | -42.86M | 362.00K | -7.85M |
| Foreign Exchange rate Adjustments | 202.00K | 430.00K | -2.06M | 466.00K | -419.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.11M | -18.78M | -1.49M | 11.08M | 6.82M |